Starting in July 2021, Professor Dr. Liliana Schaefer will take over the new Editor-in-Chief of the American Journal of Physiology-Cell Physiology.
Dr. Schaefer is an expert in Matrix biology, Pharmacology and Nephropharmacology and has contributed significantly to the field of Physiology by unraveling that two components of the extracellular matrix, decorin and biglycan, act as endogenous “danger” signals when in soluble form in the blood and body fluids.
She is a Professor of Pharmacology at the Institute of Pharmacology and Toxicology, Goethe University in Frankfurt, Germany and Adjunct Research Professor of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Philadelphia, USA. In addition, Liliana Schaefer has been PI of SFB 1177 since the first funding period in 2016 and is currently represented with her E02-project “Selective autophagy network in diabetic nephropathy”.
Links: